
Susan T Tran
Examiner (ID: 251, Phone: (571)272-0606 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1618, 1615 |
| Total Applications | 1909 |
| Issued Applications | 1053 |
| Pending Applications | 242 |
| Abandoned Applications | 650 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20391738
[patent_doc_number] => 20250367213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-04
[patent_title] => IMMEDIATE RELEASE MULTILAYER TABLET
[patent_app_type] => utility
[patent_app_number] => 19/301647
[patent_app_country] => US
[patent_app_date] => 2025-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19301647
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/301647 | IMMEDIATE RELEASE MULTILAYER TABLET | Aug 14, 2025 | Pending |
Array
(
[id] => 20277727
[patent_doc_number] => 20250302969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE
[patent_app_type] => utility
[patent_app_number] => 19/238194
[patent_app_country] => US
[patent_app_date] => 2025-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19238194
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/238194 | PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE | Jun 12, 2025 | Pending |
Array
(
[id] => 20320020
[patent_doc_number] => 20250332108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
[patent_app_type] => utility
[patent_app_number] => 19/221432
[patent_app_country] => US
[patent_app_date] => 2025-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19221432
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/221432 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | May 27, 2025 | Pending |
Array
(
[id] => 20178263
[patent_doc_number] => 20250262221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => IMMEDIATE RELEASE MULTILAYER TABLET
[patent_app_type] => utility
[patent_app_number] => 19/190529
[patent_app_country] => US
[patent_app_date] => 2025-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19190529
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/190529 | IMMEDIATE RELEASE MULTILAYER TABLET | Apr 24, 2025 | Pending |
Array
(
[id] => 20185855
[patent_doc_number] => 12396955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Tamper resistant dosage forms
[patent_app_type] => utility
[patent_app_number] => 19/174583
[patent_app_country] => US
[patent_app_date] => 2025-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 57361
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19174583
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/174583 | Tamper resistant dosage forms | Apr 8, 2025 | Issued |
Array
(
[id] => 20231199
[patent_doc_number] => 20250288518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS
[patent_app_type] => utility
[patent_app_number] => 19/171169
[patent_app_country] => US
[patent_app_date] => 2025-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19171169
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/171169 | METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS | Apr 3, 2025 | Pending |
Array
(
[id] => 19830795
[patent_doc_number] => 20250082581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => TAMPER RESISTANT DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 18/953603
[patent_app_country] => US
[patent_app_date] => 2024-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18953603
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/953603 | Tamper resistant dosage forms | Nov 19, 2024 | Issued |
Array
(
[id] => 19752861
[patent_doc_number] => 20250041426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE
[patent_app_type] => utility
[patent_app_number] => 18/921291
[patent_app_country] => US
[patent_app_date] => 2024-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18921291
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/921291 | Pharmaceutical compositions comprising bupropion and cysteine | Oct 20, 2024 | Issued |
Array
(
[id] => 19938870
[patent_doc_number] => 12310984
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-05-27
[patent_title] => Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals
[patent_app_type] => utility
[patent_app_number] => 18/830440
[patent_app_country] => US
[patent_app_date] => 2024-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18830440
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/830440 | Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals | Sep 9, 2024 | Issued |
Array
(
[id] => 19613135
[patent_doc_number] => 20240398815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/794390
[patent_app_country] => US
[patent_app_date] => 2024-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18794390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/794390 | Adagrasib solid pharmaceutical compositions | Aug 4, 2024 | Issued |
Array
(
[id] => 19570233
[patent_doc_number] => 20240374525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/784276
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/784276 | ADAGRASIB SOLID PHARMACEUTICAL COMPOSITIONS | Jul 24, 2024 | Pending |
Array
(
[id] => 19526503
[patent_doc_number] => 20240350405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => FAST DISINTEGRATING TABLET
[patent_app_type] => utility
[patent_app_number] => 18/760150
[patent_app_country] => US
[patent_app_date] => 2024-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18760150
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/760150 | FAST DISINTEGRATING TABLET | Jun 30, 2024 | Pending |
Array
(
[id] => 19430838
[patent_doc_number] => 20240299336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 18/666141
[patent_app_country] => US
[patent_app_date] => 2024-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666141
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/666141 | SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME | May 15, 2024 | Abandoned |
Array
(
[id] => 19768340
[patent_doc_number] => 20250049766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/665330
[patent_app_country] => US
[patent_app_date] => 2024-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665330
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/665330 | HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION | May 14, 2024 | Pending |
Array
(
[id] => 19417323
[patent_doc_number] => 20240293446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => TCM THROAT TEA METHOD AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/661506
[patent_app_country] => US
[patent_app_date] => 2024-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18661506
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/661506 | TCM THROAT TEA METHOD AND COMPOSITION | May 9, 2024 | Abandoned |
Array
(
[id] => 19343467
[patent_doc_number] => 20240252430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => ALLERGENIC PROTEIN FORMULATIONS FOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/629431
[patent_app_country] => US
[patent_app_date] => 2024-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/629431 | ALLERGENIC PROTEIN FORMULATIONS FOR IMMUNOTHERAPY | Apr 7, 2024 | Pending |
Array
(
[id] => 19593136
[patent_doc_number] => 12150954
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-11-26
[patent_title] => Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals
[patent_app_type] => utility
[patent_app_number] => 18/618702
[patent_app_country] => US
[patent_app_date] => 2024-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4336
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18618702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/618702 | Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals | Mar 26, 2024 | Issued |
Array
(
[id] => 19447183
[patent_doc_number] => 20240307313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/609809
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609809
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609809 | OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF | Mar 18, 2024 | Pending |
Array
(
[id] => 19960379
[patent_doc_number] => 12329851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Long acting injectable formulation comprising risperidone and biodegradable polymers
[patent_app_type] => utility
[patent_app_number] => 18/585349
[patent_app_country] => US
[patent_app_date] => 2024-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 28057
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585349
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/585349 | Long acting injectable formulation comprising risperidone and biodegradable polymers | Feb 22, 2024 | Issued |
Array
(
[id] => 19730181
[patent_doc_number] => 12208167
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-28
[patent_title] => Coated tablets for pH-dependent release of benzgalantamine
[patent_app_type] => utility
[patent_app_number] => 18/434155
[patent_app_country] => US
[patent_app_date] => 2024-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 24124
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434155
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/434155 | Coated tablets for pH-dependent release of benzgalantamine | Feb 5, 2024 | Issued |